Adolescent depression and the treatment gap by Rice, Frances et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/96903/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Rice, Frances, Eyre, Olga, Riglin, Lucy and Potter, Robert 2017. Adolescent depression and the
treatment gap. The Lancet Psychiatry 4 (2) , pp. 86-87. 10.1016/S2215-0366(17)30004-4 file 
Publishers page: http://dx.doi.org/10.1016/S2215-0366(17)30004-4
<http://dx.doi.org/10.1016/S2215-0366(17)30004-4>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
Adolescent depression and the treatment gap 
 
Frances Rice1 PhD, Olga Eyre1 MRCPsych, Lucy Riglin1 PhD and Robert Potter1 
FRCPsych 
 
1 MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological 
Medicine and Clinical Neurosciences, Cardiff University, UK 
 
Correspondence: Frances Rice, MRC Centre for Neuropsychiatric Genetics and Genomics, 
Division of Psychological Medicine and Clinical Neurosciences, Hadyn Ellis Building, Maindy 
Road, Cardiff University, CF24 4HQ, UK 
Email: ricef2@cardiff.ac.uk  
Phone: 00 44 (0)29 20 688384 
 
Adolescence is an important risk period for the development of depression, when rates of 
major depressive disorder (MDD) and symptoms rise markedly.1  Depressive symptoms and 
disorder are common in adolescence and are associated with poor long-term mental health, 
social and educational outcomes.  Adolescent MDD is often unrecognised and untreated 
despite evidence that duration of untreated depressive illness is a key factor in predicting 
recurrence in adult life.2  A paper in this issue of Lancet Psychiatry demonstrates the 
beneficial effect of mental health service contact during adolescence on subsequent 
depressive symptomatology.3  In a longitudinal community study, Neufeld and colleagues 
show that, among 14-year old adolescents with a DSM-IV psychiatric disorder, use of mental 
health services substantially reduces depressive symptomatology at 36 month follow-up.  
Thus, by age 17, the odds of adolescents who had a disorder but without mental health 
service use reporting depressive symptoms in the clinical range was seven times higher than 
in adolescents who did access services.  Importantly, these findings were generated using 
statistical methods that balance confounders across intervention and control groups (akin to 
what is done in randomised controlled trials).  
 
Depression has a complex multifactorial aetiology involving both familial/genetic and social 
risk factors and there are multiple routes to depression.1  Clinical symptoms or disorders 
may also act as precursors for depression.  For instance, low mood, anxiety, oppositional 
behavior and ADHD have all individually been found to precede depression.4,5 In the study 
by Neufeld and colleagues, mental health service contact resulted in improvement in 
depression symptoms in a group with a range of diagnoses.  This is interesting and raises 
the question of how long-term beneficial effects on depressive symptoms came about for a 
seemingly disparate group of individuals.  It would be informative to see if the beneficial 
effect on depressive symptoms was driven by a particular diagnostic group.  Clearly, it was 
beyond the scope of the present paper to assess the mechanisms involved in how 
symptoms were reduced. Nonetheless, it may be worthwhile to speculate about potential 
mechanisms to help identify the ‘active ingredients’ of treatment effects.6  These may differ 
depending on whether depressive symptoms are the primary or secondary presenting 
complaint.  Interpersonal stress and relationships (with family, peers and teachers), self-
representations and engagement in enjoyable activities are all thought to be important in the 
development of depressive symptomatology and functioning in these areas may also be 
affected by a range of disorders. For example, oppositional and neurodevelopmental 
problems may lead to profound social and academic failures, affecting self-representations, 
interpersonal relationships and vulnerability to depression.7  Effectively treating a range of 
psychiatric difficulties could potentially result in an amelioration in depressive symptoms over 
time.8  The pathways involved in the long-term beneficial effects on depressive 
symptomatology observed in the Neufeld study are not currently understood.  It seems likely 
there will multiple mechanisms and investigating whether mechanisms may differ for 
depression compared to other symptom outcomes might shed light on the active ingredients 
of interventions.   
 It is recognised that many teenagers with a psychiatric disorder do not access or receive 
interventions.  Consistent with this, the majority (62%) of the individuals with a psychiatric 
disorder in the Neufeld et al study had not accessed any mental health services in the past 
year.  Those individuals showed fewer antisocial traits and disorder, more anxiety disorders 
and less comorbidity than those accessing treatment.  This suggests that individuals with 
particular diagnoses (i.e. anxiety) may be less likely to access services but is also consistent 
with the threshold for access to Child and Adolescent Mental Health Service (CAMHS) being 
high and typically involving more complex cases with high levels of comorbidity and 
impairment.  Interestingly, the beneficial effects of mental health service contact on later 
depressive symptoms in the Neufeld study were restricted to those that met diagnostic 
criteria for a psychiatric disorder (or had high sub-threshold symptoms plus functional 
impairment).  This finding illustrates that diagnostic status is a good proxy for how well young 
people respond to treatment at least as far as depressive symptoms are concerned.  This 
suggests that children with mental health symptoms should be adequately assessed to 
determine access to specialist CAMHS and therapeutic intervention. Thus, training, tools 
and resources to support potential referrers in detecting key psychiatric symptoms and 
functional impairment may help increase the proportion of referrals to specialist mental 
health services where young people have a clear clinical need.  This may also help to 
address the treatment gap where significant numbers of young people with a diagnosis do 
not access services.  
 
In conclusion, this paper is important in empirically demonstrating the long-term beneficial 
effects of prompt treatment of adolescent mental health problems and provides hope that 
this could be achieved with interventions of relatively short duration. 
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